Philips Q2 Margin Tops Forecasts

Royal Philips NV(PHIAa) reported that its operating profitability in the second quarter of 2026 surpassed market expectations. The Dutch company, which produces products ranging from ultrasound scanners to electric toothbrushes, posted an adjusted EBITA margin of 16.4% for the quarter. This performance was stronger than the average analyst estimate of 11.9% for adjusted EBITA margin. The result highlights an earnings beat at the operating level in the latest reported period.

The company’s business mix, with a significant presence in medical technology, played a central role in the quarter. Management highlighted demand for medical scanners as a key driver of results. This demand environment helped support margins despite external cost pressures from tariffs. As a result, underlying operating performance benefited from both market demand and specific one-off factors.

Tariffs remained a headwind for the business in the second quarter, weighing on profitability. However, Philips’(PHIAa) reported adjusted EBITA margin of 16.4% included a benefit from US tariff refunds. These refunds reduced the net burden of tariffs in the period, contributing positively to the margin outcome. The combination of tariff-related costs and refunds formed an important backdrop to the quarter’s financial performance.

The impact of the US tariff refund was characterized as a contributor rather than the sole source of margin improvement. Tariff refunds provided a direct financial boost that was recognized in the quarter’s adjusted EBITA figure. At the same time, the company still had to manage ongoing tariffs that affected its cost base. The net effect was that the refund partially offset these pressures, helping Philips deliver a margin above consensus expectations.

Demand for Philips’ medical scanners was strong enough to outweigh the negative impact of tariffs on profitability. The company’s healthcare imaging equipment, including scanner systems, saw robust orders and utilization. This demand underpinned revenue and supported operating leverage in the quarter. As volumes held up, Philips was better able to absorb tariff-related costs within its broader cost structure.

The performance of the medical scanner segment thus complemented the benefit from the US tariff refunds. Together, these factors allowed Philips to achieve a 16.4% adjusted EBITA margin versus the 11.9% average expectation. The quarter illustrates how product demand in key medical technology lines can offset macro headwinds such as tariffs. It also shows how one-time tariff-related items can influence reported profitability in a given period.